Quick Takeaways
- This page summarizes Robert Eckert's Form 4 filing for AMGEN INC (AMGN).
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 12 Aug 2022, 17:38.
Robert Eckert - 10 Aug 2022 Form 4 Insider Report for AMGEN INC (AMGN)
- Role
- Director
- Signature
- /s/ Andrea Robinson, Attorney-in-Fact for Mr. Eckert
- Issuer symbol
- AMGN
- Transactions as of
- 10 Aug 2022
- Net transactions value
- -$143
- Form type
- 4
- Filing time
- 12 Aug 2022, 17:38:53 UTC
- Previous filing
- 25 May 2022
- Next filing
- 18 Aug 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Robert Eckert filed Form 4 for AMGEN INC (AMGN) on 12 Aug 2022."
What Changed
- Previous filing in this sequence was filed on 25 May 2022.
- Current net transaction value: -$143.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMGN | Common Stock | Options Exercise | $1,711,800 | +20,000 | +137% | $85.59 | 34,575 | 10 Aug 2022 | Direct | |
| transaction | AMGN | Common Stock | Tax liability | $1,711,943 | -6,791 | -20% | $252.09 | 27,784 | 10 Aug 2022 | Direct | F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AMGN | Nqso (Right to Buy) | Options Exercise | $0 | -20,000 | -100% | $0.000000* | 0 | 10 Aug 2022 | Common Stock | 20,000 | $85.59 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Non-market exercise of a total of 20,000 stock options expiring January 28, 2023 wherein 6,791 shares, in the aggregate, issuable pursuant to the exercise of these options were withheld by the Company to cover the option exercise price with the remaining shares delivered to the reporting person. |
| F2 | These shares include 2,008 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount. |